|
2',3'-Dideoxyadenosine-5'-Triphosphate
|
DB02189 |
|
|
Equilin
|
DB02187 |
[An estrogenic steroid produced by horses. It has a total of four double bonds in the A- and B-ring. High concentration of equilin is found in the urine of pregnant mares.] |
|
N-Methylmesoporphyrin Containing Copper
|
DB02188 |
|
|
K-252a
|
DB02152 |
|
|
(4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-4-benzamido-5-oxopentanoic acid
|
DB03483 |
|
|
L-Alpha-Glycerophosphorylethanolamine
|
DB03484 |
|
|
3-sulfino-L-alanine
|
DB02153 |
|
|
5,10-Dimethylene Tetrahydromethanopterin
|
DB03481 |
|
|
8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide
|
DB03482 |
|
|
Methionine Phosphonate
|
DB02151 |
|
|
Brequinar Analog
|
DB03480 |
|
|
Octyl triazone
|
DB15469 |
|
|
Silicic acid
|
DB14138 |
|
|
Iscotrizinol
|
DB15468 |
|
|
Palmitoyl tetrapeptide-7
|
DB14137 |
|
|
Hydroxyethyl ethylcellulose
|
DB14139 |
[Hydroxyethyl ethylcellulose modulates bacterial binding to salivary pellicle; moderately effective in preventing plaque formation.] |
|
Benzhydrocodone
|
DB15465 |
[Benzhydrocodone is a benzylic prodrug of hydrocodone.[L4894] It was developed in an effort to reduce parenteral bioavailability of the active metabolite as a deterrent to abuse.[A182177] Benzhydrocodone is indicated for use in the short-term management of pain. It was first approved by the FDA in February 2018 in combination with [acetaminophen] under the trade name Apadaz, marketed by KVK Tech and developed by KemPharm.[L7859,L7862]] |
|
Octyldodecanol
|
DB14134 |
|
|
Urolithin A
|
DB15464 |
[Urolithin A is a metabolite of ellagic acid. It has been demonstrated to stimulate mitophagy and improve muscle health in old animals and in preclinical models of aging.[A179494]] |
|
Cinoxate
|
DB15467 |
|
